The Relationship of Genetic Polymorphism Micromal Epoxide Hydrolase (EPHX1) His139Arg and Lung Cancer

Authors

  • Rosidah Hanum Hasibuan Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Sumatera Utara
  • Noni Novisari Soeroso Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Sumatera Utara
  • Setia Putra Tarigan Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Sumatera Utara
  • Yahwardiah Siregar Department of Biomedical Science, Faculty of Medicine, University of Sumatera Utara
  • Erna Mutiara Department of Biostatistics, Faculty of Public Health, University of Sumatera Utara
  • Lucia Aktalina Department of Biomedical Science, Faculty of Medicine, University of Sumatera Utara

DOI:

https://doi.org/10.36497/jri.v42i2.305

Keywords:

Polymorphism, EPHX1, His139Arg, PCR-RFLP, Lung cancer.

Abstract

Background: Microsomal epoxide hydrolase 1 (EPHX1) plays an important role in both activation and detoxification of polycyclic aromatic hydrocarbons (PAH) and aromatic amines. Polymorphism EPHX1 His139Arg in susceptibility to lung cancer has been reported with inconsistent outcomes. Aim of this study was to analyze the relationship between this polymorphism and lung cancer in smokers.

Method: Consecutive sampling and case-control study was applied. Genotyping was performed by PCR-RFLP assay. The chi-square test with p<0.05 considered as significant.

Results: Of all 84 subjects, in case and control groups, wild-type variant His139His were 34 (81%) and 30 (71.4%), heterozygote variant His139Arg were 8 (19%) and 12 (28.6%), there was no homozygote variant Arg139Arg identified. (p=0.36).

Conclusion: The EPHX1 His139His represents a common polymorphism in both of subject groups. There is no association between His139Arg polymorphism of EPHX1 and lung cancer.

Downloads

Download data is not yet available.

References

Kiyohara C, Yoshimasu K, Takayama K, and Nakanishi Y. 2006. EPHX1 Polymorphisms and the Risk of Lung Cancer: a huge review. Epidemiology,17: 89–99.

Liu H, Li HY, Chen HJ, Huang YJ, Zhang S, Wang J. 2013. EPHX1 A139G Polymorphism and Lung Cancer Risk : a meta-analysis. Tumor Biol, 34 : 155-163.

Graziano C, Comin CE, Crisci C, Novelli L, Politi L et al. 2009. Functional Polymorphisms of The Microsomal Epoxide Hydrolase Gene : A Reappraisal on a Early-onset Lung Cancer Patients Series : Lung Cancer. Elsevier, 63 : 187-193.

Erkisi Z, Eraltan IY, Turna A, Gormus U, Canlica H et al. 2010. Polymorphisms in the Microsomal Epoxide Hydrolase Gene : Role in Lung Cancer Susceptibility and Prognosis. Tumori, 96 : 756-763.

Zhou W, Thurston SW, Liu G, Xu LL, Miller DD et al. 2001. The Interaction between Microsomal Epoxide Hydrolase Polymorphisms and Cumulative Cigarette Smoking in Different Histological Subtypes of Lung Cancer. Cancer Epidemiol Biomarkers, 10: 461-466

Hoffmann D, Hoffmann I. 1997. The changing cigarette, 1950-1995. J Toxicol Environ Health ;50(4):307–64.

Gondodiputro, S. 2007. "Bahaya tembakau dan bentuk-bentuk sediaan tembakau." Bagian Ilmu Kesehatan Masyarakat Fakultas Kedokteran Universitas Padjadjar. dalam Mustikaningrum, S. 2010. Perbedaan kadar trigliserida darah pada perokok dan bukan perokok. Doctoral dissertation, Universits Sebelas Maret Fakultas Kedokteran

Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P. et al. 2003. Association of Microsomal Epoxide Hydrolase Polymorphisms and Lung Cancer Risk. British Journal of Cancer, 89: 702–706.

Hecht SS. 2003. Tobacco Carcinogens, Their Biomarkers and Tobacco-Induced Cancer. Nature Reviews Cancer, 3: 733-744.

Downloads

Published

2022-04-13

Issue

Section

Original Article

Similar Articles

1-10 of 139

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)